| |
Available On-Demand In life sciences today, being able to store, access and use data, no matter where it’s hosted, is crucial. Access this webinar on-demand for an important look at how to make sure the data and applications for critical research work is fully accessible, while also ensuring it is protected and secure. View now. 
|
|
| By Gabrielle Masson The Trump administration is exploiting an administrative loophole to keep federal research funding frozen, despite a federal judge ordering for a halt to the action, according to Nature. |
|
|
|
By Kevin Dunleavy Private equity firms Carlyle and SK Capital have agreed to pay $29 million to acquire bluebird bio, which has struggled to commercialize three gene therapy products. |
By Conor Hale After hundreds of FDA employees were suddenly laid off last weekend, including dozens at the agency’s device center, the government has begun rescinding some of those cuts and attempting to rehire lost workers. |
By Darren Incorvaia Celia Witten, M.D., Ph.D., is no longer deputy director of the FDA’s Center for Biologics Evaluation and Research, joining a long list of health agency leaders who have departed since President Donald Trump began his second term in office. |
|
Wednesday, March 5, 2025 | 12pm ET / 9am PT Join us for a valuable discussion on how flexible and scalable outsourced sales models are reshaping pharma. Explore strategies to navigate industry trends and evolving regulations and leverage AI, smart tech, and innovative governance to boost team performance. Register today. 
|
|
By Darren Incorvaia Even as President Donald Trump wages a very public fight against diversity, equity and inclusion initiatives in the government and beyond, several large drugmakers say running diverse clinical trials is not optional or extraneous, but a core part of the work they do. |
By Kevin Dunleavy Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. The Outsourcing Facilities Association and a Texas-based compounder have filed a lawsuit against the FDA in U.S. District Court in Fort Worth for declaring the shortage over for Novo's semaglutide. |
By Angus Liu Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia B product Beqvez. The move leaves no active gene therapy programs in Pfizer's portfolio. |
By Kevin Dunleavy At a press conference in Washington, D.C. dubbed “Lilly in America,” the Indianapolis drugmaker said it will begin construction on four new production facilities in the U.S. The effort will more than double what the company has earmarked for domestic drug manufacturing since 2020, bringing the total outlay to more than $50 billion. |
By Nick Paul Taylor The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. |
By Darren Incorvaia Researchers studying a deadly virus discovered a key protein behind its lethality and successfully used antibodies to stop that protein from causing dangerous fluid leakage in mice. |
Fierce podcasts Don’t miss an episode |
| Senior Editor Heather Landi, Senior Writer Paige Minemyer and Staff Writer Emma Beavins reflect on their trip to the ViVE conference in Nashville and what they learned. |
|
|---|
|
|
|
Tuesday, March 4, 2025 | 2pm ET / 11am PT Learn expert strategies for overcoming the unique challenges of early phase clinical trials, from preparing investigational products to maintaining blinding and sourcing controlled substances. This webinar provides actionable insights to optimize pharmacy activities and ensure trial success. Register now. 
|
|
Whitepaper This paper reviews key developments in the oncology market during 2024 and outlines what they mean for the future. Presented by Blue Matter, strategic consultants in the life sciences |
Whitepaper There’s so much that goes into making sure your therapy maximizes impact every step of the way. Sponsored by: Accredo By Evernorth |
| Submissions Open Early August |
|
|
| |
|
